Abolfazl Akbari

9PUBLICATIONS
11CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Medical biochemistry - proteins and peptides (incl. medical proteomics)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|May 08, 2026
Gene Expression Levels of Ferroptosis Suppressor Protein (FSP1) and Ferroptosis Inducer (ACSL4) and Their Correlation With Clinicopathological Features in Colorectal Cancer Patients.

|May 04, 2026
The association of smoking and opium consumption with the risk and prognosis of colorectal cancer: A multicenter retrospective cohort study.

|Oct 25, 2025
Impact of hypertension and angiotensin receptor blockers on colorectal cancer: A retrospective study.

Mohammad Rezazadeh, Shahram Agah, Amirreza Kamyabi

|Sep 15, 2025
Assessment of Expression LncRNA-xloc-000303, lncRNA-LOC152578 and hsa-miR-29a in Patients Diagnosed With Colon Cancer in the Pre-Treatment Stage.

Elham Tahami, Abolfazl Akbari, Reza Nekouian

|Oct 30, 2024
The dysregulation and clinical relevance of lncRNAs MYOSLID and SFTA1P in colorectal cancer patients.

Amir Reza Karamzadeh, Mansour Heidari, Abolfazl Namazi

|Feb 08, 2020
Serum or plasma; which is a more competent molecular source for investigating the blood-based tumor-specific miRNA biomarkers?

Sara Eslamizadeh, Abolfazl Akbari

Pageof 2

Frequent Collaborators

2 joint publications

Alireza Mirzaei

1 joint publications

Hassan Mehrad-Majd

1 joint publications

Ebrahim Faghihloo

1 joint publications

Sara Eslamizadeh